Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (411-420 of 424) with videos related to

Pageof 43
Sort By:
Science (New York, N.Y.)|May 9, 1997
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infectionW Cavert, D W Notermans, K Staskus, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Vaccine|August 21, 2007
A sensitive cell-based assay for the detection of residual infectious West Nile virusM H Koldijk, J A Bogaards, S Kostense, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
Investigative Ophthalmology & Visual Science|November 14, 2025
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic StudyGijsbert J Hötte, P Martijn Kolijn, Maaike de Bie, et al.
AIDS (London, England)|February 24, 2001
Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997E L Op de Coul, M Prins, M Cornelissen, et al.
The Journal of General Virology|January 8, 1999
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzeesW M Bogers, W H Koornstra, R H Dubbes, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
The Journal of General Virology|July 19, 2006
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cellsM Havenga, R Vogels, D Zuijdgeest, et al.
Pageof 43

Showing results (411-420 of 424) with videos related to

Sort By:
Pageof 43
Science (New York, N.Y.)|May 9, 1997
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infectionW Cavert, D W Notermans, K Staskus, et al.
Annals of Internal Medicine|February 12, 1998
Association between CCR5 genotype and the clinical course of HIV-1 infectionA M de Roda Husman, M Koot, M Cornelissen, et al.
Vaccine|August 21, 2007
A sensitive cell-based assay for the detection of residual infectious West Nile virusM H Koldijk, J A Bogaards, S Kostense, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
Investigative Ophthalmology & Visual Science|November 14, 2025
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic StudyGijsbert J Hötte, P Martijn Kolijn, Maaike de Bie, et al.
AIDS (London, England)|February 24, 2001
Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997E L Op de Coul, M Prins, M Cornelissen, et al.
The Journal of General Virology|January 8, 1999
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzeesW M Bogers, W H Koornstra, R H Dubbes, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
The Journal of General Virology|July 19, 2006
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cellsM Havenga, R Vogels, D Zuijdgeest, et al.
Pageof 43